Melphalan and myeloma. Experience with a low-dose continuous regimen.
D001847:Bone Diseases / Q000150:complications; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D009461:Neurologic Manifestations; D011241:Prednisone / Q000627:therapeutic use; D014520:Urethane / Q000627:therapeutic use
D014520:Urethane; D008558:Melphalan; D011241:Prednisone